aluminum hydroxide, magnesium hydroxide, drug combination has been researched along with atropine in 3 studies
| Studies (aluminum hydroxide, magnesium hydroxide, drug combination) | Trials (aluminum hydroxide, magnesium hydroxide, drug combination) | Recent Studies (post-2010) (aluminum hydroxide, magnesium hydroxide, drug combination) | Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) |
|---|---|---|---|---|---|
| 253 | 100 | 17 | 26,711 | 1,259 | 1,697 |
| Protein | Taxonomy | aluminum hydroxide, magnesium hydroxide, drug combination (IC50) | atropine (IC50) |
|---|---|---|---|
| cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | 21.41 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 1.012 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.0067 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0007 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0009 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0015 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.0021 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.354 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rahwan, RG; Stephens, RL; Wong, WS | 1 |
| Bodemar, G; Gotthard, R; Ström, M; Walan, A | 1 |
| Chan, TC; Davis, DP; Jin, A; Vilke, GM | 1 |
2 trial(s) available for aluminum hydroxide, magnesium hydroxide, drug combination and atropine
| Article | Year |
|---|---|
Antacid/anticholinergic, cimetidine, and placebo in treatment of active peptic ulcers.
Topics: Aluminum Hydroxide; Antacids; Atropine; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Guanidines; Humans; Magnesium; Magnesium Hydroxide; Placebos; Recurrence; Stomach Ulcer; Time Factors | 1981 |
Prospective randomized study of viscous lidocaine versus benzocaine in a GI cocktail for dyspepsia.
Topics: Adult; Aluminum Hydroxide; Anesthetics, Local; Antacids; Atropine; Benzocaine; Drug Combinations; Drug Therapy, Combination; Dyspepsia; Female; Humans; Lidocaine; Magnesium Hydroxide; Male; Phenobarbital; Prospective Studies; Scopolamine; Simethicone; Single-Blind Method; Treatment Outcome | 2004 |
1 other study(ies) available for aluminum hydroxide, magnesium hydroxide, drug combination and atropine
| Article | Year |
|---|---|
Examination of the potential antiulcer activity of the calcium antagonist propyl-methylenedioxyindene. III. Lack of effect on cysteamine-induced duodenal ulcers in rats.
Topics: Aluminum Hydroxide; Animals; Antacids; Anti-Ulcer Agents; Atropine; Bethanechol Compounds; Calcium Channel Blockers; Cysteamine; Dopamine; Drug Combinations; Duodenal Ulcer; Female; Gastric Acid; Gastrointestinal Motility; Indenes; Magnesium Hydroxide; Rats; Rats, Inbred Strains; Stomach Ulcer; Verapamil | 1990 |